COVID-19 has impacted antimicrobial drug prescribing both directly, through COVID-19 treatment, and indirectly, through the reduced spread of illnesses for which antimicrobial drugs are commonly prescribed.
Office of Science and Data Policy (SDP)
The Office of Science and Data Policy is the departmental focal point for policy research, analysis, evaluation, and coordination of department-wide public health science policy and data policy activities and issues. The Office provides authoritative advice and analytical support to the ASPE and departmental leadership on public health science policy and data policy issues and initiatives, coordinates science and data policy issues of interagency scope within HHS, and manages interagency initiatives in science policy and data policy. The Office works closely with staff from across the Department on strategic plan development and implementation efforts. The Offices also carries out a program of policy research, analysis, evaluation, and data development in these issues.
The Office of Science and Data Policy includes several components:
- Division of Science and Public Health Policy
- Division of Evidence, Evaluation and Data Policy
- Division of Strategic Planning
Topic Areas:
- HHS Data Council
- Regulatory Impact Analysis
- Strategic Planning
- Information Quality Guidelines
- Prevention and wellness
- Public health systems and functions
- Food safety and nutrition
- Drugs and devices
- Tobacco control and prevention
- Biomedical research and development
- Economic analysis
- Emergency preparedness, response, and recovery
- Data and statistical policy
- Health disparities and vulnerable populations
- Health information technology
- Microsimulation
- Privacy policy
Reports
Displaying 11 - 20 of 114. 10 per page. Page 2.
Advanced SearchASPE Issue Brief
Trends in Antimicrobial Drug Prescribing During the COVID-19 Pandemic
September 20, 2021
Report
Comprehensive Plan for Addressing High Drug Prices: A Report in Response to the Executive Order on Competition in the American Economy
September 9, 2021
President Biden’s Executive Order 14036, “Promoting Competition in the American Economy” (the Competition Executive Order), identifies a lack of competition as a key driver for problems across economic sectors.
ASPE Issue Brief
The Impact of the COVID-19 Pandemic on Major HHS Data Systems
August 30, 2021
The COVID-19 pandemic and policy responses, including stay-at-home orders and expanded use of telework, disrupted data collection for major HHS data systems. This brief identifies the impact of the pandemic on 29 HHS statistical surveys and administrative data systems widely used by policymakers and the public.
Report
Valuing COVID-19 Mortality and Morbidity Risk Reductions in U.S. Department of Health and Human Services Regulatory Impact Analyses
August 20, 2021
This report develops an approach for valuing COVID-19 mortality and morbidity risk reductions based on the U.S. Department of Health and Human Services (HHS) Guidelines for Regulatory Impact Analysis. Valuing risk reductions associated with regulations or other policies that address the novel coronavirus disease 2019 (COVID-19) presents major challenges.
ASPE Issue Brief
Unvaccinated for COVID-19 but Willing: Demographic Factors, Geographic Patterns, and Changes Over Time
August 9, 2021
As of August 4, 2021, 70.1 percent of U.S. adults have received at least one dose of a COVID-19 vaccine. However, vaccine coverage varies dramatically across the country, with vaccine coverage being less than 40 percent in a third of U.S. counties. Despite a sufficient supply of COVID-19 vaccines, daily vaccinations have dwindled in recent months.
Report
Appendix D: Updating Value per Statistical Life (VSL) Estimates for Inflation and Changes in Real Income
June 29, 2021
The HHS Guidelines for Regulatory Impact Analysis (2016) discuss an approach to valuing mortality risk reductions, commonly referred to as the value per statistical life (VSL). This appendix provides background information on the VSL estimates, describes the process for updating these values, reports the estimates in 2020 dollars, and illustrates their application.
Report
Vaccine Hesitancy for COVID-19: State, County, and Local Estimates
June 16, 2021
To support state and local communication and outreach efforts, ASPE developed state, county, and sub-state level predictions of hesitancy rates using the most recently available federal survey data, the Household Pulse Survey from May 26-June 7, 2021. This page includes an interactive map, a pdf file with a methodological description, and datasets for download.
Physician Understanding and Willingness to Prescribe Biosimilars: Findings from a US National Survey
May 17, 2021
This study presents the findings of a national survey of physicians about their knowledge of biosimilar biological products as well as the impact of biological product naming conventions on prescriber choice.
Related Products
Department of Health & Human Services Evaluation Policy
May 12, 2021
This is an evaluation policy for the Department of Health and Human Services (HHS), required by the Foundations for Evidence-based Policymaking Act of 2018 (Evidence Act). ASPE convened a group of agency representatives from across HHS operating and staff divisions to develop the policy.
Department of Health & Human Services FY 2022 Evaluation Plan
May 12, 2021
As part of the Evidence Act, HHS is required to submit “an evaluation plan describing activities the agency plans to conduct pursuant to [its evidence-building plan].” Nine operating divisions within HHS and one staff division developed evaluation plans and included information on priority questions being examined by the agencies as well as data, methods, and challenges to addressing those ques